Genetic Association Between Hypoplastic Left Heart Syndrome and Cardiomyopathies

Jeanne L Theis1, Jessie J Hu2, Rhianna S Sundsbak1

  • 1Cardiovascular Genetics Research Laboratory (J.L.T., R.S.S., T.M.O.), Mayo Clinic, Rochester, MN.

Insights

Genetic variants in cardiomyopathy genes are linked to hypoplastic left heart syndrome (HLHS), suggesting shared genetic causes for structural and myopathic heart conditions. This finding may indicate reduced functional reserve in single-ventricle circulation.

Area of Science:

  • Cardiovascular Genetics
  • Developmental Biology
  • Genomics

Background:

  • Hypoplastic left heart syndrome (HLHS) is a severe congenital heart defect often associated with poor outcomes.
  • Genetic overlap between HLHS and myopathic heart diseases, particularly involving MYH6 variants, has been suggested.

Purpose of the Study:

  • To investigate genetic links between HLHS and cardiomyopathy-associated genes using whole genome sequencing.
  • To identify specific gene variants contributing to HLHS and assess their association with cardiomyopathies.

Main Methods:

  • Whole genome sequencing was performed on 197 HLHS probands, 43 family members, and 813 controls.
  • Rare variant burden testing was conducted across 56 cardiomyopathy genes in HLHS cases versus controls.
  • Data analysis included filtering for rare, segregating variants and applying Bonferroni correction for multiple testing.

Main Results:

  • Pathogenic variants in MYBPC3 and RYR2 were identified in families with HLHS and various cardiomyopathies (hypertrophic, dilated, noncompaction).
  • Significant enrichment of rare variants was found in MYH6 (P=0.000068) in HLHS cases compared to controls.
  • Rare, damaging MYH6 variants were present in 10% of HLHS probands, including those with familial congenital heart disease and compound heterozygosity.

Conclusions:

  • Whole genome sequencing revealed defects in cardiomyopathy genes in HLHS patients.
  • These genetic defects may compromise the functional reserve of the single-ventricle circulation in HLHS survivors.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
173
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
280
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
128
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
193
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
250
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K